Literature DB >> 16955051

Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension.

Yiqian Zhu1, Michael T Lawton, Rose Du, Yamin Shwe, Yongmei Chen, Fanxia Shen, William L Young, Guo-Yuan Yang.   

Abstract

OBJECTIVE: Experimentally, a fistula created surgically between the carotid artery and jugular vein, together with occlusion of venous sinuses, generate venous hypertension, which can induce dural arteriovenous fistula formation intracranially in rats. Our aim was to study the effect of nonischemic venous hypertension on the elaboration of the angiogenic signal, hypoxia-inducible factor-1 (HIF-1), and its downstream signal, vascular endothelial growth factor (VEGF).
METHODS: Sixty rats were exposed to venous hypertension for periods ranging from 4 hours to 3 weeks. Western blot analysis, transbinding assays, enzyme-linked immunosorbent assays, and immunohistochemistry quantified HIF-1 and VEGF expression in brain. Forty-eight control rats underwent similar surgical procedures without creating venous hypertension. Cerebral blood flow was measured at baseline, after surgery, and before sacrifice.
RESULTS: Venous hypertension did not impair cerebral blood flow. Relative to controls, HIF-1 expression increased fivefold in response to venous hypertension (P < 0.005), with peak expression 1 day later localized to endothelial cells in venules next to the sagittal sinus. VEGF expression also increased threefold in response to venous hypertension (P < 0.05), with peak expression 7 days later localized to parasagittal astrocytes. HIF-1 and VEGF were minimally expressed in rat normal venous pressures.
CONCLUSION: In this model, venous hypertension stimulates angiogenesis by a mechanism other than ischemia. HIF-1 expression may result from dilation of parasagittal veins and endothelial deformation. HIF-1 and VEGF seem to be molecular agents that convert venous hypertension into intracellular signals and angiogenesis activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955051     DOI: 10.1227/01.NEU.0000228962.68204.CF

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  30 in total

1.  Expression of NF-E2-related factor 2 in a rat dural arteriovenous fistula model.

Authors:  Limin Dou; Wenhua Yu
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

Review 2.  Biology of cerebral arteriovenous malformations with a focus on inflammation.

Authors:  Nikolaos Mouchtouris; Pascal M Jabbour; Robert M Starke; David M Hasan; Mario Zanaty; Thana Theofanis; Dale Ding; Stavropoula I Tjoumakaris; Aaron S Dumont; George M Ghobrial; David Kung; Robert H Rosenwasser; Nohra Chalouhi
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

3.  Developmental venous anomalies with capillary stain: a subgroup of symptomatic DVAs?

Authors:  Luca Roccatagliata; René van den Berg; Michael Soderman; Anne Boulin; Stéphanie Condette-Auliac; Georges Rodesch
Journal:  Neuroradiology       Date:  2011-06-11       Impact factor: 2.804

Review 4.  The role of angiogenesis in dural arteriovenous fistulae: the story so far.

Authors:  Pervinder Bhogal; Leonard L Yeo; Hans Henkes; Timo Krings; Michael Söderman
Journal:  Interv Neuroradiol       Date:  2018-03-21       Impact factor: 1.610

5.  Cognitive decline and hypersomnolence: thalamic manifestations of a tentorial dural arteriovenous fistula (dAVF).

Authors:  Neha Morparia; Gary Miller; Alejandro Rabinstein; Giuseppe Lanzino; Neeraj Kumar
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

Review 6.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

7.  Thrombophilia Due to Factor V and Factor II Mutations and Formation of a Dural Arteriovenous Fistula: Case Report and Review of a Rare Entity.

Authors:  Sam Safavi-Abbasi; Federico Di Rocco; Peter Nakaji; Guenther C Feigl; Alireza Gharabaghi; Madjid Samii; Anton Valavanis; Amir Samii
Journal:  Skull Base       Date:  2008-03

8.  Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice.

Authors:  F Shen; Y Fan; H Su; Y Zhu; Y Chen; W Liu; W L Young; G-Y Yang
Journal:  Gene Ther       Date:  2007-10-25       Impact factor: 5.250

Review 9.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

10.  Nonischemic cerebral venous hypertension promotes a pro-angiogenic stage through HIF-1 downstream genes and leukocyte-derived MMP-9.

Authors:  Peng Gao; Yiqian Zhu; Feng Ling; Fanxia Shen; Brian Lee; Rodney Allanigue Gabriel; Qi Hao; Guo-Yuan Yang; Hua Su; William L Young
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.